Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
7.63
+0.04 (0.53%)
Dec 10, 2025, 4:00 PM EST - Market closed
Lifecore Biomedical Revenue
Lifecore Biomedical had revenue of $31.11M in the quarter ending September 30, 2025, with 25.92% growth. This brings the company's revenue in the last twelve months to $135.27M, up 5.31% year-over-year. In the fiscal year ending May 25, 2025, Lifecore Biomedical had annual revenue of $128.87M with 0.47% growth.
Revenue (ttm)
$135.27M
Revenue Growth
+5.31%
P/S Ratio
2.06
Revenue / Employee
$317,406
Employees
406
Market Cap
285.87M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 25, 2025 | 128.87M | 606.00K | 0.47% |
| May 26, 2024 | 128.26M | 24.99M | 24.20% |
| May 28, 2023 | 103.27M | -8.00M | -7.19% |
| May 29, 2022 | 111.27M | 10.40M | 10.31% |
| May 30, 2021 | 100.87M | -59.19M | -36.98% |
| May 31, 2020 | 160.07M | -397.49M | -71.29% |
| May 26, 2019 | 557.56M | 33.33M | 6.36% |
| May 27, 2018 | 524.23M | 54.45M | 11.59% |
| May 28, 2017 | 469.78M | -7.14M | -1.50% |
| May 29, 2016 | 476.92M | -62.34M | -11.56% |
| May 31, 2015 | 539.26M | 62.44M | 13.10% |
| May 25, 2014 | 476.81M | 35.11M | 7.95% |
| May 26, 2013 | 441.71M | 124.16M | 39.10% |
| May 27, 2012 | 317.55M | 40.82M | 14.75% |
| May 29, 2011 | 276.73M | 38.51M | 16.16% |
| May 30, 2010 | 238.22M | 2.29M | 0.97% |
| May 31, 2009 | 235.94M | -2.59M | -1.09% |
| May 25, 2008 | 238.53M | 28.03M | 13.32% |
| May 27, 2007 | 210.50M | -21.46M | -9.25% |
| May 28, 2006 | 231.95M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
LFCR News
- 3 days ago - Halper Sadeh LLC Encourages Lifecore Biomedical, Inc. Shareholders to Contact the Firm to Discuss Their Rights - Business Wire
- 4 weeks ago - Lifecore Biomedical to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - Lifecore Biomedical, Inc. (LFCR) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Lifecore Biomedical Reports Financial Results for the Three Months Ended September 30, 2025, and Provides Corporate Update - GlobeNewsWire
- 5 weeks ago - Lifecore Biomedical to Report Financial Results for the Three Months Ended September 30, 2025, on November 6, 2025 - GlobeNewsWire
- 6 weeks ago - Lifecore Biomedical Selected as New Commercial Manufacturing Partner by Leading Global Pharmaceutical Company - GlobeNewsWire
- 6 weeks ago - Lifecore and PolyPeptide Announce Collaboration Intended to Offer End-to-End Peptide Manufacturing Solution for U.S. Market - GlobeNewsWire
- 2 months ago - Lifecore Biomedical to Participate at Upcoming Industry Conferences and Events - GlobeNewsWire